KENDRA STORM: Open Payments
NPI 1033752183 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 27 payments from 21 companies in 2025. Trend: 2023 $680 · 2024 $136 · 2025 $699
Food & beverage: $600Education: $99
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $129 |
| Smith+Nephew, Inc. | 1 | $75 |
| SERVIER PHARMACEUTICALS LLC | 3 | $69 |
| Integra LifeSciences Corporation | 1 | $44 |
| Janssen Biotech, Inc. | 2 | $37 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $32 |
| Aveo Pharmaceuticals, Inc. | 1 | $30 |
| Elucent Medical | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: Trodelvy, STRAVIX MESH, Tibsovo, ACCLARENT AERA, TECVAYLI, NERLYNX, FOTIVDA, IMFINZI.
Industry payments across SD — which companies pay providers there.
